The International Congress on Antiphospholipid Antibodies (aPL) is held every three years to discuss the recent advances and future directions in aPL and Antiphospholipid Syndrome (APS). On behalf of the Local and International Executive Committees, it is my pleasure to invite you to the 15th International Congress on aPL, which will take place in Istanbul, Turkey, on September 21-24, 2016.
The 15th International Congress on aPL, with the support of Turkish Society of Rheumatology, will cover a very comprehensive program including:
Evidence-based state-of-the art presentations from internationally recognized physicians and scientists
Task Force discussions and presentations covering the controversial aspects of diagnosis and management
Oral and poster submitted abstract presentations
Meet the professor sessions
Patient sessions guided by leaders in the field.
Turkey is centrally located at the crossroads of continents with 12,500 years of history. Istanbul is a city where two continents merge and where history is combined with modern life. I hope that the 15th International Congress on aPL will similarly bring together rheumatologists, hematologists, thrombosis specialists, obstetricians, neurologists, immunologists, internists, and all others researchers and specialists interested in aPL/APS to advance the field.
Doruk Erkan, MD, MPH
Clinical Co-Director, Mary Kirkland Center for Lupus Care,
Associate Physician-Scientist, The Barbara Volcker Center for Women and Rheumatic Disease,
Associate Attending Physician, Hospital for Special Surgery,
Associate Professor of Medicine, Weill Cornell Medical College, New York, NY, US